Amgros 2027 2.1390.b

This tender is generally well-structured with a clear description and adequate financial information. However, it lacks specific details on evaluation criteria and technical/financial requirements, impacting its completeness and practicality.

The tender adheres to open procedure rules and specifies a proper CPV code. Deadlines are provided, though their reasonableness is not fully assessable without context. No disputes are indicated. Regulatory compliance is assumed based on the procedure type.

The description of the procurement's purpose and the nature of the framework agreements (non-exclusive, no purchase obligation) is clear. However, the absence of specified evaluation criteria and detailed technical/financial requirements reduces overall clarity.

Basic information such as title, reference, organization, estimated value, and deadline are present. However, crucial details regarding technical capability, financial requirements, and contract duration are missing, impacting the completeness of the documentation.

The tender is an open procedure, allowing broad access. The non-exclusive nature and lack of purchase obligation for hospital pharmacies promote fairness. Access to documents is provided, and the value is disclosed. Criteria for evaluation are not specified, which could be a concern.

The tender specifies e-procurement, which is positive. However, the lack of explicit information on contract start date, financing details, and the absence of direct document content (requiring external access) reduce its practicality.

Key fields like title, reference, organization, value, and deadline are populated. The status is 'active', and no suspension or disputes are noted. Dates appear logical within the provided context.

There is no explicit mention of green procurement, social aspects, or innovation within the provided tender details. This suggests a lack of focus on sustainability criteria.